See All Slides - tctmd.com

Slides

Presentation TCT 2012

TWENTE 2-Year: A Prospective, Randomized Trial of Everolimus-Eluting vs. Zotarolimus-Eluting Stents

Presenter: Clemens von Birgelen

October 25, 2012

Presentation TCT 2012

IVUS-Guided PCI: From Stent Sizing to Predicting Thrombosis and Restenosis

Presenter: Gary Mintz

October 25, 2012

Presentation TCT 2012

Dynamic Obstruction: Mechanisms and Implications for Treatment

Presenter: Carey Kimmelstiel

October 25, 2012

Presentation TCT 2012

What Is FFR, and How Is It Different from Other Indices?

Presenter: William Fearon

October 25, 2012

Presentation TCT 2012

For: The Transaortic Approach Has Clear Benefits Over the Transapical Approach!

Presenter: Vinayak Bapat

October 25, 2012

Presentation TCT 2012

First-in-Man Results with a Novel Nanoparticle-Based Sirolimus-Coated Balloon in Coronary In-Stent Restenosis Lesions (Concept Medical)

Presenter: Suhas Lele

October 25, 2012

Presentation TCT 2012

Case Review 3: How to Decide About a Second Clip for DMR

Presenter: Richard Smalling

October 25, 2012

Presentation TCT 2012

The European TAVR “Test Track”: After 5 Years, Have TAVR Use Patterns Drifted Out of Control?

Presenter: Nicolo Piazza

October 25, 2012

Presentation TCT 2012

4q25 and Prediction of Atrial Fibrillation: How Can This Information Help the Clinician?

Presenter: Paddy Barrett

October 25, 2012

Presentation TCT 2012

Statement: Second Generation DES Are Safer Than BMS and Should Be Used in All Patients

Presenter: Marco Valgimigli

October 25, 2012

Advertisement

Slides

TWENTE 2-Year: A Prospective, Randomized Trial of Everolimus-Eluting vs. Zotarolimus-Eluting Stents

IVUS-Guided PCI: From Stent Sizing to Predicting Thrombosis and Restenosis

Dynamic Obstruction: Mechanisms and Implications for Treatment

What Is FFR, and How Is It Different from Other Indices?

For: The Transaortic Approach Has Clear Benefits Over the Transapical Approach!

First-in-Man Results with a Novel Nanoparticle-Based Sirolimus-Coated Balloon in Coronary In-Stent Restenosis Lesions (Concept Medical)

Case Review 3: How to Decide About a Second Clip for DMR

The European TAVR “Test Track”: After 5 Years, Have TAVR Use Patterns Drifted Out of Control?

4q25 and Prediction of Atrial Fibrillation: How Can This Information Help the Clinician?

Statement: Second Generation DES Are Safer Than BMS and Should Be Used in All Patients

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content